Multivariate analysis of recurrence and progression in stage T1 transitional cell bladder carcinoma: Prognostic value of p53 and ki67

Article Spanish OPEN
Rodríguez Alonso, A.; Pita Fernández, S.; González Carreró, J.; Nogueira March, J.L.;
(2003)
  • Publisher: Asociación Española de Urología
  • Subject: Recurrence | Progresión | Recidiva | Progression | ki67 | Pronóstico | Bladder neoplasm | Prognosis | Neoplasia vesical | p53

OBJETIVO: Establecer los factores pronósticos de recidiva y progresión en el carcinoma de células transicionales de vejiga en estadio T1, prestando especial atención al valor pronóstico de p53 y ki67. MATERIAL Y MÉTODOS: 175 pacientes con tumor vesical incidente de la c... View more
  • References (20)
    20 references, page 1 of 2

    11. WITJES JA, KIEMENEY LALM, SCHAAFSMA HE, DEBRUYNE FMJ: The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial. Br J Urol 1994; 73: 172-176.

    12. HERMANN GG, HORN T, STEVEN K: The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer. J Urol 1998; 159: 91-94.

    13. LINDEN MD, NATHANSON SD, ZARBO RJ: Evaluation of anti-p53 antibody staining. Quality control and technical considerations. Appl Immunohistochem 1994; 2 (3): 218-224.

    14. MOSTOFI FK, SOBIN LH, TORLANI H: Histological typing of urinary bladder tumors. En International Histological Classification of Tumours. Nº 10: Geneva: World Health Organization, 1973.

    15. HERMANEK P, HUTTER RVP, SOBIN LH: TNM Atlas. Illustrated guide to the TNM/pTNM classification of malignant tumours. Separata de la 4ª Edición en Inglés. Berlin, Heidelberg: Springer-Verlag; 1997: 263-326.

    16. ALLARD P, BERNARD P, FRADET Y, TÊTU B: The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index. Br J Urol 1998; 81: 692-698.

    17. WITJES JA, KIEMENEY LALM, VERBEEK ALM, HEIJBROEK RP, DEBRUYNE FMJ: Random bladder biopsies and the risk of recurrent superficial bladder cancer: a prospective study in 1026 patients. World J Urol 1992; 10: 231-234.

    18. PFISTER C, LACOMBE L, VEZINA MC, MOORE L, LARUE H, TÊTU B, et al: Prognostic value of the proliferative index determined by ki-67 immunostaining in superficial bladder tumors. Hum Pathol 1999; 11: 1350-1355.

    19. OJEA-CALVO A, PÉREZ-GARCÍA MD, RODRÍGUEZALONSO A, DOMÍNGUEZ-FREIRE F, ALONSORODRIGO A, RODRÍGUEZ IGLESIAS B, et al: Cáncer superficial de vejiga: ¿qué controles han de seguir y durante cuanto tiempo, los pacientes libres de tumor?. Actas Urol Esp 1998; 22: 210-214.

    10. MILLÁN-RODRÍGUEZ F, CHÉCHILE-TONIOLO G, SALVADOR-BAYARRI J, PALOU J, VICENTERODRÍGUEZ J: Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 2000; 163: 73-78.

  • Similar Research Results (2)
  • Metrics
Share - Bookmark